⚕ Rx (Prescription Required)Oncology & Critical CareTargeted Therapies & Kinase Inhibitors

Lapatinib

Active pharmaceutical substance formulated in Jan Aushadhi generic products for Oncology & Critical Care treatment.

🧴 Clinical Application

Take orally 1250 mg (five 250 mg tablets) once daily continuously on an EMPTY STOMACH: at least 1 hour before or 1 hour after a meal with a full glass of water. Swallow tablets whole. Do not divide doses.

⚠️ Side Effects

Common: Diarrhea (frequent, onset typically within 6 days), acneiform rash, nausea, hand-foot syndrome (with capecitabine), fatigue, stomatitis. Rare/Severe: Decreased left ventricular ejection fraction (LVEF / cardiomyopathy), severe hepatotoxicity, severe interstitial lung disease, and QT prolongation.

🛡️ Safety Warnings

Black Box Warning: Severe hepatotoxicity; monitor liver transaminases every 4 to 6 weeks. Perform baseline and periodic echocardiography (LVEF evaluation). Must be taken on an empty stomach. Proactively manage diarrhea with loperamide at the first loose stool. Avoid grapefruit juice.

Jan Aushadhi Products containing Lapatinib

Found 1 generic formulation(s) containing this active ingredient.

⚕ Rx OnlyTargeted Therapies & Kinase Inhibitors

Lapatinib Tablets 250mg

Tablets
30's Bottle

Lapatinib Tablets (250mg) is an oral dual tyrosine kinase inhibitor of both EGFR (ErbB1) and HER2/neu (ErbB2) on the PMBI formulary. It reversibly binds to the intracellular ATP-binding domain of both receptors, inhibiting receptor phosphorylation and shutting down downstream MAPK and PI3K/Akt survival cascades in HER2-overexpressing tumor cells. Able to cross the blood-brain barrier. Indicated in combination with capecitabine for advanced or metastatic HER2-positive breast cancer progressing after prior trastuzumab, anthracyclines, and taxanes, and with letrozole for hormone receptor-positive/HER2-positive breast cancer.

₹2710₹6338.6757% saved
Lapatinib

Brand Equivalents & Price Comparison

Compare Jan Aushadhi generic prices against popular commercial brands for Lapatinib.

Generic FormulationPack SizeJan Aushadhi PriceCommercial Brand EquivalentsAvg. Commercial PriceSavings
Lapatinib Tablets 250mg30's Bottle₹2710.00LANIB, HER, HER 2NIB, LIBSET, ETIBO₹6338.6757% Save

Frequently Asked Questions (FAQ)

Get answers to common queries about Lapatinib generics.

How many Jan Aushadhi products contain Lapatinib?＋
This directory currently lists 1 Jan Aushadhi generic product(s) containing Lapatinib as an active pharmaceutical ingredient (API). The count reflects the July 2026 PMBI catalog snapshot.
Does Lapatinib require a prescription at Jan Aushadhi Kendras?＋
Yes. Lapatinib is classified as a prescription-required (Rx) ingredient under applicable Indian drug schedules. You must present a valid prescription from a registered medical practitioner to obtain it at a Jan Aushadhi Kendra.
What is the lowest listed price for Lapatinib at Jan Aushadhi?＋
Based on the July 2026 PMBI catalog, the lowest listed MRP for a Lapatinib formulation is ₹2710.00. Individual prices vary by pack size and dosage form. Use the product links above for the exact MRP of each formulation.
Are Jan Aushadhi Lapatinib products clinically equivalent to branded versions?＋
Jan Aushadhi generics contain the same declared active pharmaceutical ingredient (Lapatinib) at the same concentration as branded counterparts and must meet CDSCO quality standards. However, inactive excipients, release mechanisms, and manufacturing processes can differ between manufacturers. Never switch a prescribed medicine without consulting your doctor.
Find a Jan Aushadhi Kendra Near You
Search 21,118 listed government pharmacies across India by PIN code. Find Lapatinib products at government prices.
Search Kendras